Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Income towards Parent Company: 2012-2019

Historic Income towards Parent Company for Larimar Therapeutics (LRMR) over the last 8 years, with Dec 2019 value amounting to -$45.4 million.

  • Larimar Therapeutics' Income towards Parent Company rose 72.55% to -$3.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$35.9 million, marking a year-over-year increase of 38.50%. This contributed to the annual value of -$45.4 million for FY2019, which is 25.68% up from last year.
  • As of FY2019, Larimar Therapeutics' Income towards Parent Company stood at -$45.4 million, which was up 25.68% from -$61.1 million recorded in FY2018.
  • Larimar Therapeutics' 5-year Income towards Parent Company high stood at -$45.4 million for FY2019, and its period low was -$74.2 million during FY2015.
  • Over the past 3 years, Larimar Therapeutics' median Income towards Parent Company value was -$52.2 million (recorded in 2017), while the average stood at -$52.9 million.
  • As far as peak fluctuations go, Larimar Therapeutics' Income towards Parent Company tumbled by 103.94% in 2015, and later increased by 25.68% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Income towards Parent Company (Yearly) stood at -$74.2 million in 2015, then rose by 22.00% to -$57.9 million in 2016, then increased by 9.84% to -$52.2 million in 2017, then declined by 17.18% to -$61.1 million in 2018, then climbed by 25.68% to -$45.4 million in 2019.